Health - Google News: FDA Approves Short-Acting Neutropenia Drug - MedPage Today

Health - Google News Google News

FDA Approves Short-Acting Neutropenia Drug - MedPage Today Aug 30th 2012, 21:04 MedPage Today FDA Approves Short-Acting Neutropenia Drug MedPage Today By Charles Bankhead, Staff Writer, MedPage Today The FDA has approved a short-acting formulation of granulocyte-colony stimulating factor (G-CSF) for managing chemotherapy-induced neutropenia. Known as tbo-filgrastim (Sicor), the parenteral agent is ... Amgen Competitor Gets Drug ApprovalLos Angeles Business Journal FDA approves Teva version of Amgen's NeupogenReuters FDA approves Teva copycat of Amgen's NeupogenChicago Tribune Medical Xpress -FiercePharma -FierceBiotech all 52 news articles »

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

Posted in: